ArticleOncoimmunology2016

Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.

Dàlia Raïch-Regué et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.